MedPath

Helping Moms Quit Pilot Trial

Not Applicable
Completed
Conditions
Smoking Cessation
Interventions
Behavioral: Moms Quit
Behavioral: Text4Baby
Registration Number
NCT05041413
Lead Sponsor
University of Kansas Medical Center
Brief Summary

The objective of this study is to test the feasibility and preliminary effectiveness of a tailored text message program to support smoking abstinence among postpartum women who smoke or recently quit.

Detailed Description

This pilot trial will evaluate a text message intervention (Moms Quit) to be initiated with postpartum women within one month of delivery. Moms Quit is a tailored program to support smoking abstinence among new mothers who are either current smokers or quit during their most recent pregnancy. Investigators will randomize 30 postpartum women, stratified by recent/current smoking status, into Moms Quit versus vs. CONTROL. Investigators hypothesize that participants receiving Moms Quit will have, on average, a significantly longer period of self-reported prolonged abstinence compared to CONTROL.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Less than one month postpartum
  • Live delivery
  • Smoked at least 100 cigarettes/lifetime
  • Smoked anytime during their most recent pregnancy
  • English-speaking
  • Own a mobile phone
  • Provide an email address
  • Willing to receive intervention-related texts
  • Willing to complete surveys
  • Willing to provide a saliva sample at the end of the study
Exclusion Criteria
  • Women whose pregnancy did not result in live birth
  • On a 7-point scale, participant indicates that they are not interested in quitting or staying quit in the next 6 months (Not at all = 1).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Moms Quit InterventionMoms Quit12 weeks of the Moms Quit text message intervention
Text4BabyText4Baby12 weeks of Text4Baby messages
Primary Outcome Measures
NameTimeMethod
Days abstinent in the past 30 days12 weeks post-randomization

Self-reported abstinence in the past 30 days

Secondary Outcome Measures
NameTimeMethod
7 day point prevalence abstinence12 weeks post-randomization

Biochemically verified 7 day point prevalence abstinence using salivary cotinine with a 13ng/ml cut off

Trial Locations

Locations (1)

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath